The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Because of the variable clinical course of multiple myeloma, the identification of prognostic parameters is of clinical interest. Therefore, we analyzed the clinical significance of serum levels of soluble human leukocyte antigen class I molecules (sHLA-I), carboxy-terminal telopeptide of type-I col...
主要な著者: | Schütt, P, Rebmann, V, Brandhorst, D, Wiefelspütz, J, Ebeling, P, Opalka, B, Seeber, S, Nowrousian, MR, Moritz, T, Grosse-Wilde, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2008
|
類似資料
-
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
著者:: Rebmann, V, 等
出版事項: (2007) -
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
著者:: Schütt, P, 等
出版事項: (2005) -
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
著者:: Schütt, P, 等
出版事項: (2005) -
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
著者:: Schütt, P, 等
出版事項: (2006) -
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
著者:: Schütt, P, 等
出版事項: (2005)